Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$191.17 - $325.63 $55 Million - $93.7 Million
287,852 New
287,852 $93.7 Million
Q3 2023

Nov 14, 2023

BUY
$194.33 - $283.97 $2.27 Million - $3.31 Million
11,659 Added 57.98%
31,767 $6.32 Million
Q2 2023

Aug 14, 2023

SELL
$223.05 - $302.68 $55.4 Million - $75.2 Million
-248,505 Reduced 92.51%
20,108 $5.74 Million
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $12.1 Million - $15 Million
69,050 Added 34.6%
268,613 $58.2 Million
Q4 2022

Feb 14, 2023

BUY
$204.38 - $296.82 $40.8 Million - $59.2 Million
199,563 New
199,563 $41 Million
Q2 2022

Aug 15, 2022

SELL
$115.91 - $214.48 $3.32 Million - $6.15 Million
-28,668 Reduced 31.56%
62,176 $11.9 Million
Q1 2022

May 16, 2022

BUY
$127.96 - $207.36 $5.86 Million - $9.49 Million
45,777 Added 101.58%
90,844 $18.8 Million
Q4 2021

Feb 14, 2022

BUY
$165.13 - $241.83 $7.44 Million - $10.9 Million
45,067 New
45,067 $8.04 Million
Q2 2021

Aug 16, 2021

SELL
$131.45 - $201.49 $25 Million - $38.3 Million
-189,900 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$92.73 - $142.05 $17.6 Million - $27 Million
189,900 New
189,900 $24.7 Million
Q4 2020

Feb 16, 2021

SELL
$67.44 - $103.72 $47.2 Million - $72.6 Million
-700,227 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$42.79 - $75.8 $20.5 Million - $36.3 Million
478,343 Added 215.58%
700,227 $53.1 Million
Q2 2020

Aug 14, 2020

BUY
$27.25 - $47.53 $6.05 Million - $10.5 Million
221,884 New
221,884 $10.5 Million
Q1 2020

May 15, 2020

SELL
$23.16 - $47.74 $4.06 Million - $8.38 Million
-175,474 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$29.4 - $44.98 $5.16 Million - $7.89 Million
175,474 New
175,474 $7.71 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.